Risk-Stratified Postoperative Follow-Up After Uncomplicated Cataract Surgery: Real-World Outcomes and Implications for Remote Care

无并发症白内障手术后风险分层术后随访:真实世界结果及其对远程医疗的启示

阅读:1

Abstract

BACKGROUND: To evaluate the clinical value of postoperative examinations at 24 hours and 30 days following uncomplicated phacoemulsification, and to identify subgroups who may safely benefit from remote or simplified follow-up pathways. METHODS: A retrospective observational study was conducted, including all patients who underwent uncomplicated phacoemulsification at a high-volume tertiary public hospital during September 2024. Demographic data, ophthalmologic history, surgical characteristics, day-1 and day-30 findings, visual outcomes, and emergency visits were extracted from electronic medical records. Postoperative complications associations were evaluated using bivariate tests and multivariate binomial logistic regression. RESULTS: Of 296 patients, the most common 24-hour complication was transient intraocular pressure elevation (13.2%). Overall, 20.9% showed a postoperative finding on day 1, and 14.2% required unplanned reassessment. At 30 days, complications occurred in 6.7% of cases, mainly cystoid macular edema (3.6%). In multivariate analysis, 24-hour complications (P=0.028) and ophthalmologic comorbidities (P=0.010) independently predicted 30-day complications. Patients without ophthalmologic history, without 24-hour complications, and with early visual improvement had a markedly lower risk of adverse outcomes. Applying a risk-based follow-up strategy could reduce approximately 50% of routine 30-day in-person reviews and relieve up to 300 hours of annual clinical workload. CONCLUSION: This risk-stratified postoperative model may improve service efficiency in high-volume public hospitals, support the sustainability of ophthalmic care, and may be transferable to other public health systems. Low-risk patients could be safely monitored remotely without compromising clinical outcomes. Prospective studies are required to confirm these findings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。